The Medicines Company Surges Amid Credit Suisse Upgrade
November 20, 2014 at 10:16 AM EST
Credit Suisse upgraded The Medicines Company (NASDAQ: MDCO) Thursday from Neutral to Outperform and raised its price target from $27 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.